Here’s a positive update on abortion: The number of terminated pregnancies in America continues to decline, and is at its lowest rate since the Roe v. Wade case in 1973.
The college football world tends to listen to Alabama’s six-time national championship coach Nick Saban. Let’s hope it heeds his complaint about playing early-season games in the daytime in the South, where temperatures can be in the 90s through most of September.
The Marion County Board of Supervisors finds itself in a difficult situation: Economic decline requires raising taxes to pay for basic services that residents demand, yet higher taxes in the long run make it more difficult to turn around the economy.
The maker of OxyContin could pay as much as $12 billion spread over time between 2,000 municipalities nationwide, including Columbia and Marion County, as part of a tentative settlement announced Wednesday, the Associated Press reported.
Mississippi’s Department of Corrections should be thrilled that anyone volunteers to come into its prisons to try to help inmates turn their lives around.
Instead, MDOC apparently doesn’t want anyone questioning what it does, including a prison minister.
These are the 12 indicia of reasonableness that the Mississippi Supreme Court has established through case law for how to decide if annexation plans are fair:
(1) the municipality's need to expand
(2) whether the area sought to be annexed is reasonably within a path of growth of the city
An experiment with creative financial assistance for 20 low-income single mothers in Jackson drew the attention of The Washington Post, which last weekend published an informative story about it.
The Aug. 27 runoff election gave further credence to the argument that the touchscreen voting machines Mississippi uses should be mothballed.
Well, the statewide candidates we backed didn’t fare well in Tuesday’s Republican primary runoff.
An Oklahoma judge’s $572 million verdict against consumer products company Johnson & Johnson for its role in the state’s opioid crisis seems likely to be reduced on appeal.
But the verdict, along with Oklahoma’s prior settlement of another lawsuit against drug manufacturer Purdue Pharma, brings something else to mind.
